Title
Complement Receptor 1 availability on red blood cell surface modulates Plasmodium vivax invasion of human reticulocytes
Date Issued
01 December 2019
Access level
open access
Resource Type
journal article
Author(s)
Prajapati S.K.
Borlon C.
Rovira-Vallbona E.
Gruszczyk J.
Menant S.
Tham W.H.
Kattenberg J.H.
De Meulenaere K.
Xuan X.N.
Urbano Ferreira M.
Niño C.H.
Patarroyo M.A.
Spanakos G.
Kestens L.
Abbeele J.V.D.
Rosanas-Urgell A.
Universidad Peruana Cayetano Heredia
Universidad Peruana Cayetano Heredia
Universidad Peruana Cayetano Heredia
Abstract
Plasmodium vivax parasites preferentially invade reticulocyte cells in a multistep process that is still poorly understood. In this study, we used ex vivo invasion assays and population genetic analyses to investigate the involvement of complement receptor 1 (CR1) in P. vivax invasion. First, we observed that P. vivax invasion of reticulocytes was consistently reduced when CR1 surface expression was reduced through enzymatic cleavage, in the presence of naturally low-CR1-expressing cells compared with high-CR1-expressing cells, and with the addition of soluble CR1, a known inhibitor of P. falciparum invasion. Immuno-precipitation experiments with P. vivax Reticulocyte Binding Proteins showed no evidence of complex formation. In addition, analysis of CR1 genetic data for worldwide human populations with different exposure to malaria parasites show significantly higher frequency of CR1 alleles associated with low receptor expression on the surface of RBCs and higher linkage disequilibrium in human populations exposed to P. vivax malaria compared with unexposed populations. These results are consistent with a positive selection of low-CR1-expressing alleles in vivax-endemic areas. Collectively, our findings demonstrate that CR1 availability on the surface of RBCs modulates P. vivax invasion. The identification of new molecular interactions is crucial to guiding the rational development of new therapeutic interventions against vivax malaria.
Volume
9
Issue
1
Scopus EID
2-s2.0-85067645951
PubMed ID
Source
Scientific Reports
Resource of which it is part
Scientific Reports
Source funding
National Center for Advancing Translational Sciences
Sponsor(s)
This work was supported by the ITM’s Secondary Research Funding (SOFI), Antwerp, Belgium. We thank the patients and clinical staff at UPCH (Iquitos Peru) and SMRU (Thailand) for their cooperation and contribution to the collection of P. vivax isolates for the ex vivo invasion assays. We are also grateful to L. Boel and A. Ceulemans and Odin Goovaerts for their support in the FACS experiments. This research was made possible thanks to the financial support of the Flemish Government (SOFI) to ARU and the FWO for the short travel grant program [K207216N to S.K.P.] and FWO-SB PhD fellowship to K.D.M.
Sources of information:
Directorio de Producción Científica
Scopus